Core Insights - The first invasive brain-computer interface (BCI) clinical trial in China is transforming the life of its subject, allowing him to control games using his thoughts, achieving efficiency comparable to that of a typical user with a touchpad [1] - China has become the second country globally, after the United States, to conduct invasive BCI clinical trials, with several metrics surpassing those of Neuralink, founded by Elon Musk [1][2] - The research is a collaboration between the Shanghai Institute of Neuroscience and Fudan University Huashan Hospital, contributing to Shanghai's goal of becoming a global technology innovation hub [1] Technology Comparison - The Shanghai BCI technology features ultra-thin and flexible electrodes, measuring only 1/5 to 1/7 the size of those used by Neuralink, significantly reducing damage to brain tissue [2] - The implanted device is the smallest globally, with a diameter of 26mm and a thickness of less than 6mm, which is half the size of Neuralink's product [2] Surgical Procedure - The surgical procedure for the invasive BCI is less invasive than Neuralink's, requiring only a small groove in the skull rather than penetrating it, making it more patient-friendly [3] Research and Development - The BCI research is led by young scientists who have returned to China, highlighting the importance of domestic talent in advancing this technology [4][5] - The Shanghai Institute has established a micro-nano electronic processing platform, enabling precise fabrication of BCI devices and accelerating research progress [6] Future Developments - The next version of the BCI system, expected by the end of this year or early next year, will feature 256 information transmission channels, four times the current capacity, and a smaller size [7] - Future applications aim to enhance motor control for paralyzed patients and potentially restore speech for those with language impairments [7] Industry Vision - The BCI technology is seen as a foundational technology for human enhancement and human-machine integration, with aspirations for consumer-level applications in the future [8] - Shanghai's "Future Industry Cultivation Action Plan" aims to establish a global innovation hub for BCI products by 2030, reflecting a clear vision for the industry's growth [8]

"The vast majority of diseases or brain issues, I think are fixable with a Neuralink device."Elon Muskhttps://t.co/FVCBNaQ8KD ...

Neuralink’s latest chip might one day let humans see in infrared light — a leap beyond restoring vision to actually enhancing it.The future of human perception is closer than ever. https://t.co/7tGeZULg8B ...

Core Insights - Neuralink has successfully enabled a monkey to "see" virtual objects through its brain-machine interface technology, which has potential applications for helping blind individuals perceive the world [1] - The device, named Blindsight, stimulates areas of the brain associated with vision, tricking the monkey's visual system into recognizing non-existent objects [1] - This marks the first public demonstration of Blindsight's experimental results, highlighting the cutting-edge nature of brain device development aimed at treating traditionally difficult medical conditions like blindness [1] Summary by Sections Technology and Innovation - Blindsight is a brain-implanted chip designed to simulate eye functions and directly stimulate the visual cortex [1] - During experiments, the monkey looked at the location of a virtual object over two-thirds of the time, indicating it perceived the non-existent target [1] Future Applications - The short-term goal of Blindsight is to assist blind individuals in seeing, while the long-term vision includes achieving "superhuman vision," such as the ability to see infrared light [2] - Neuralink is also advancing another project aimed at helping paralyzed individuals interact with computers using their thoughts [2] Human Trials - Currently, five humans have received Neuralink implants, with three implanted in 2024 and two in 2025, and some participants reportedly use the brain-machine device for up to 60 hours per week [2]

作为迅速发展的脑机科技领域中的公司之一，Neuralink还在为瘫痪患者植入脑机接口设备， 使其可以直接与计算机交互。 据马斯克介绍，目前已有5位人类接受了Neuralink的植入。其中3人在2024年完成，另外2人 在2025年接受了植入。根据O'Doherty的演讲，有些患者每周使用设备的时间多达60小时。 马斯克表示，未来类似的脑机接口设备可能会让瘫痪人士重新获得行动能力，甚至恢复行走。 结果显示，猴子在测试过程中至少三分之二的时间内，都会将视线转向研究人员"试图让其大 脑产生视觉效果的物体"。 这是Neuralink首次公开Blindsight的实验数据，这个脑机接口设备旨在模拟眼睛的功能，是 脑机接口技术的前沿探索领域之一，正试图打破传统医学无法治愈疾病的边界。 需要指出的是，与其他所有动物实验一样，目前尚不清楚这些结果能否应用于人类，这一设备 尚未获得在美国获准用于人体。 马斯克曾表示，Blindsight的短期目标是"让人类重新获得视力"，长期目标则是实现"超人的 视觉"，比如感知红外线。 Neuralink过去几年一直在猴子身上测试该设备，并希望今年能开始人体实验——马斯克曾在 今年3月公开表 ...

Core Viewpoint - The article highlights the successful initiation of China's first invasive brain-computer interface (BCI) clinical trial, marking a significant advancement in the field and positioning China as the second country globally to enter this phase after the United States [1]. Group 1: Clinical Trial and Patient Outcomes - The clinical trial involves a male subject who lost all four limbs due to an electric shock accident. Since the implantation of the BCI device in March 2025, the system has operated stably without infections or electrode failures for over a month. The subject achieved functionalities such as playing chess and racing games within 2-3 weeks of training, demonstrating control comparable to that of a typical user with a computer touchpad [1]. - The BCI system is expected to significantly improve the quality of life for patients with complete spinal cord injuries, double upper limb amputations, and amyotrophic lateral sclerosis once it receives approval for registration and market launch [1]. Group 2: Technological Advancements - The BCI system developed by the research teams is noted for having the smallest and most flexible neural electrodes globally, with a cross-sectional area only 1/5 to 1/7 that of Neuralink's electrodes. This design minimizes damage to brain tissue and enhances compatibility with neural interfaces [2]. - The system is the only one in China to have received a registration-type inspection report and can stably collect single-neuron spike signals, providing a solid data foundation for applications [3]. Group 3: Surgical and Operational Efficiency - The implanted device has a diameter of 26mm and a thickness of less than 6mm, making it the smallest brain-controlled implant globally, only half the size of Neuralink's product. This allows for a less invasive surgical procedure, reducing risks and recovery time [3]. - The design of the BCI system is based on principles of neuroscience, allowing for similar control levels to Neuralink with fewer implanted electrodes, thus minimizing patient risk [4]. Group 4: Future Applications - Following successful trials in non-human primates, the project team aims to enable the subject to control a robotic arm for physical tasks such as grasping and holding objects. Future developments may include controlling complex physical devices like robotic dogs and intelligent agents, thereby expanding the subject's capabilities in daily life [4].

Core Viewpoint - The development of brain-computer interface (BCI) technology in China is rapidly advancing, with the country becoming the second globally to enter clinical trials for invasive BCI technology after the United States [1][5]. Group 1: Clinical Trial Progress - The first invasive BCI clinical trial in China has been successfully conducted in collaboration with the Chinese Academy of Sciences and Fudan University Huashan Hospital [1]. - The trial's participant, who lost limbs due to an electrical accident, has demonstrated the ability to control a cursor on a computer and play games within 2-3 weeks of training after the implantation surgery [3]. Group 2: Technology and Innovation - Invasive BCIs are categorized as having the highest technical challenges and barriers, with the only previous clinical trial being conducted by Neuralink [5]. - The Chinese-developed invasive BCI system is coin-sized and features ultra-flexible neural electrodes that are implanted into the brain tissue through minimally invasive surgery, with each electrode having 32 sensors to capture weak neural signals [5]. Group 3: Future Implications - The technology has the potential to significantly improve the quality of life for individuals with disabilities, such as restoring vision, speech, and mobility, as well as providing better interventions for conditions like stroke and Alzheimer's disease [6]. - Furthermore, this cutting-edge technology could revolutionize communication with the external world, enabling not only brain control but also the ability to write information directly into the brain, paving the way for a future of human-machine coexistence [6].

Core Insights - The article highlights the successful initiation of China's first invasive brain-computer interface (BCI) clinical trial, marking a significant advancement in the field, making China the second country after the United States to enter this phase [1] Group 1: Clinical Trial Details - The clinical trial was conducted by the Chinese Academy of Sciences' Brain Science and Intelligent Technology Center in collaboration with Fudan University Huashan Hospital, focusing on a male subject who lost all four limbs due to an electrical accident [1] - The implanted BCI device has shown stable operation since its implantation in March 2025, with no infections or electrode failures reported over a month [1] - The subject achieved functionalities such as playing chess and racing games within 2-3 weeks of training, demonstrating control comparable to that of a typical user with a computer touchpad [1] Group 2: Technological Advancements - The BCI system developed by the Zhao Zhengtuo and Li Xue teams features the world's smallest and most flexible neural electrodes, with a cross-sectional area only 1/5 to 1/7 that of Neuralink's electrodes, and flexibility exceeding Neuralink's by a factor of 100 [2] - This ultra-flexible electrode allows for high-density, large-area, and long-term stable neural signal acquisition, addressing key challenges in tissue compatibility and bandwidth limitations for implanted BCIs [2] Group 3: Surgical and Operational Efficiency - The BCI system is the only one in China with a registered report that can stably capture single-neuron spike signals, providing a solid data foundation for applications [3] - The device's dimensions are 26mm in diameter and less than 6mm in thickness, making it the smallest brain-controlled implant globally, requiring only a small recess in the skull for implantation, thus reducing surgical risks and recovery time [3] - The standardized operational procedures based on mature surgical techniques facilitate scalable applications in various medical institutions [3] Group 4: Future Applications - The BCI system is designed to achieve similar control levels as Neuralink with fewer implanted electrodes, minimizing patient risk while maximizing benefits [5] - Prior to human trials, the system's safety and functionality were validated in non-human primates, where it successfully controlled computer cursor movement through neural activity [5] - Future plans include enabling the subject to control robotic arms for physical tasks, expanding the potential for interaction with complex devices like robotic dogs and intelligent agents [5]

Core Viewpoint - China's first prospective clinical trial of an invasive brain-computer interface (BCI) has been successfully conducted, making it the second country globally to enter the clinical trial phase after the United States [1] Group 1: Clinical Trial Details - The clinical trial's subject is a 37-year-old male who lost his limbs due to a high-voltage accident. Since the implantation of the BCI device in March, the system has operated stably without infections or electrode failures for over a month [3] - The subject has achieved a level of control over a computer touchpad comparable to that of a normal person, allowing him to play chess and racing games using only his thoughts after 2-3 weeks of adaptive training [3] Group 2: Technological Advancements - The implanted device is the smallest brain-controlled implant globally, measuring 26mm in diameter and less than 6mm in thickness, which is half the size of Neuralink's product [8] - The flexible neural electrodes developed by the research team are 1/5 to 1/7 the cross-sectional area of those used by Neuralink, providing better compatibility with brain tissue and reducing damage [5] Group 3: Research and Development - The research team has established a comprehensive approach to BCI research, covering various aspects such as motion perception, neural function repair, decoding algorithms, and wireless system development since 2022 [5] - The dynamic optimization of the neural decoder has been achieved through an online learning framework, allowing real-time motion decoding and overcoming the limitations of traditional static decoding models [9] Group 4: Future Prospects - The BCI system is expected to improve the quality of life for patients with complete spinal cord injuries, double upper limb amputations, and amyotrophic lateral sclerosis by enabling them to control external devices [12] - Future trials will aim to allow the subject to use robotic arms for physical tasks, expanding the potential applications of the technology [12]

Core Insights - The article highlights the significant progress in brain-machine interface (BMI) technology, particularly focusing on China's first invasive BMI clinical trial, marking a milestone in the medical application of this technology [1][2][11] - The Chinese research team has developed the world's smallest and most flexible neural electrodes, which are now in clinical trials, positioning China as the second country after the United States to enter this phase [1][5] Group 1: Clinical Trial Details - The invasive BMI clinical trial was successfully conducted by a collaboration between the Chinese Academy of Sciences and Fudan University, with the first subject being a male patient who lost his limbs due to an electrical accident [2][11] - The system has shown stable operation since its implantation in March 2025, with no infections or electrode failures reported, allowing the patient to perform tasks like playing chess and racing games within 2 to 3 weeks of training [4][10] Group 2: Technological Advancements - The neural electrodes developed by the Chinese team have a cross-sectional area that is 1/5 to 1/7 of those used by Neuralink, with flexibility exceeding Neuralink's by over 100 times, minimizing damage to brain tissue [5][8] - The implanted BMI system is capable of long-term stable collection of single-neuron spike signals, providing a solid data foundation for applications in neuroprosthetics [5][7] Group 3: Surgical and Operational Innovations - The BMI system features a compact design with a diameter of 26mm and a thickness of less than 6mm, allowing for a minimally invasive surgical procedure that reduces risks and recovery time [7][11] - The surgical procedure utilized advanced imaging techniques to create a detailed 3D model of the patient's brain, ensuring precise electrode placement [11][13] Group 4: Future Applications and Research Directions - The research team aims to expand the functionality of the BMI system to enable patients to control robotic arms and other external devices, enhancing their quality of life [11][12] - Future developments may incorporate machine learning and artificial intelligence to interpret more complex signals, potentially allowing for communication through thought [11][12]